Funded Tech Companies

Aegle Therapeutics

Aegle Therapeutics, operating out of Miami, raised money through Tellus International, DEFTA Partners and DeepWork Capital.

Company Overview

Contact Information

Company Background Information

Overview

Aegle Therapeutics Corp. is a first in class, Phase 1/2a ready, biotechnology company isolating extracellular vesicles (EVs) from allogeneic bone marrow derived mesenchymal stem cells to treat severe dermatological conditions, including burns and epidermolysis bullosa (EB), a rare pediatric connective tissue disorder, and to prevent scarring.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/1/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Shelley Hartman

        

Chief Scientific Officer

Evangelos Badiavas

        

Controller

Patricia Chicvara

        

VP - Operations

Heidi Kempinski

        

Company Investors

• Tellus International (Lonnie Moulder)
• DEFTA Partners (Elona Baum)
• DeepWork Capital
• New World Angels (David Schimmel)
• Ocean Azul Partners

Browse more funded tech companies:

Aegle | Aeglea BioTherapeutics

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary